STOCK TITAN

Longeveron to Present at the Planet MicroCap Showcase

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Longeveron Inc. (NASDAQ: LGVN) will be presenting at the Planet MicroCap Showcase on May 1-2, 2024. The presentation will take place on May 1, 2024, at 4:30 p.m. PT. Investors can register for 1x1 meetings with the company and attend the showcase in person at the Paris Hotel & Casino in Las Vegas, NV.
Longeveron Inc. (NASDAQ: LGVN) presenterà al Planet MicroCap Showcase il 1 e 2 maggio 2024. La presentazione avrà luogo il 1 maggio 2024, alle 16:30 PT. Gli investitori possono registrarsi per incontri individuali con la società e partecipare di persona al showcase presso il Paris Hotel & Casino di Las Vegas, NV.
Longeveron Inc. (NASDAQ: LGVN) presentará en el Planet MicroCap Showcase el 1 y 2 de mayo de 2024. La presentación se llevará a cabo el 1 de mayo de 2024, a las 4:30 p.m. PT. Los inversores pueden registrarse para reuniones uno a uno con la empresa y asistir en persona al evento en el Paris Hotel & Casino en Las Vegas, NV.
Longeveron Inc. (나스닥: LGVN)는 2024년 5월 1일부터 2일까지 Planet MicroCap Showcase에서 발표할 예정입니다. 발표는 2024년 5월 1일 오후 4시 30분 PT에 진행됩니다. 투자자들은 회사와의 1대1 미팅을 등록하고 라스베이거스의 파리 호텔 & 카지노에서 개최되는 쇼케이스에 직접 참석할 수 있습니다.
Longeveron Inc. (NASDAQ : LGVN) présentera au Planet MicroCap Showcase les 1er et 2 mai 2024. La présentation aura lieu le 1er mai 2024 à 16h30 PT. Les investisseurs peuvent s'inscrire pour des réunions en tête-à-tête avec l'entreprise et assister en personne au salon au Paris Hotel & Casino de Las Vegas, NV.
Longeveron Inc. (NASDAQ: LGVN) wird am 1. und 2. Mai 2024 auf dem Planet MicroCap Showcase präsentieren. Die Präsentation findet am 1. Mai 2024 um 16:30 Uhr PT statt. Investoren können sich für Einzelgespräche mit dem Unternehmen registrieren und die Präsentation persönlich im Paris Hotel & Casino in Las Vegas, NV besuchen.
Positive
  • None.
Negative
  • None.

MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Planet MicroCap Showcase, taking place May 1-2, 2024.

Details for the Company’s presentation:

 Date:Wednesday, May 1, 2024
 Time:4:30 p.m. PT
 Webcast:Click Here
   

An archived replay of the webcast will be available on the “Events & Presentations” section of the Company’s website following the conference.

If you would like to book 1x1 investor meetings with Longeveron Inc. and to attend the Planet MicroCap Showcase: VEGAS 2024, please register here: https://planetmicrocapshowcase.com/signup.

1x1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV.

About Longeveron Inc.

Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B™, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty. For more information, visit www.longeveron.com or follow Longeveron on LinkedIn, X, and Instagram.

Investor Contact:

Derek Cole
Investor Relations Advisory Solutions 
derek.cole@iradvisory.com


FAQ

When will Longeveron Inc. present at the Planet MicroCap Showcase?

Longeveron Inc. will present at the Planet MicroCap Showcase on May 1, 2024.

What time will Longeveron Inc.'s presentation take place?

Longeveron Inc.'s presentation will take place at 4:30 p.m. PT on May 1, 2024.

Where will the Planet MicroCap Showcase be held?

The Planet MicroCap Showcase will be held at the Paris Hotel & Casino in Las Vegas, NV.

How can investors register for 1x1 meetings with Longeveron Inc.?

Investors can register for 1x1 meetings with Longeveron Inc. by visiting https://planetmicrocapshowcase.com/signup.

Longeveron Inc.

NASDAQ:LGVN

LGVN Rankings

LGVN Latest News

LGVN Stock Data

8.40M
1.13M
6.71%
14.27%
1.12%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
MIAMI

About LGVN

longeveron llc is a leading global regenerative medicine company developing innovative cellular therapeutics for chronic life-threatening diseases. our lead investigational product candidate (lmsc) is based on a specialized cell known as a mesenchymal stem cell that is derived from the bone marrow of healthy young adult donors. our allogeneic, ‘off-the-shelf’ product is under investigation for chronic conditions of the elderly, and other life- threatening diseases, for which no approved therapeutics currently exist: • aging frailty syndrome • alzheimer’s disease • hypoplastic left heart syndrome • the metabolic syndrome